BASFY to Divest Optical Brightening Agent Business to Catexel

Core Insights - BASF SE has signed a definitive agreement to divest its optical brightening agent business to Catexel, aligning with its 'Winning Ways' strategy for portfolio transformation [1][6] - The transaction includes the Monthey facility in Switzerland and approximately 80 employees, reflecting BASF's focus on businesses closely integrated into its core value chains [2][6] - The divestment supports BASF's strategy to actively manage its portfolio and prioritize key segments while entrusting the business to a new owner with the capability to develop its potential [3] Financial and Operational Details - Financial details of the transaction were not disclosed, and it is subject to standard regulatory and closing conditions, with an anticipated closing in the first quarter of 2026 [2][6] - Catexel plans to integrate the optical brightening agent business into its specialty chemicals portfolio, which includes products for detergents, cleaning, personal care, and industrial applications [3] Market Performance - BASF SE remains a leading supplier and innovator in the home care and industrial cleaning markets post-divestiture, with shares gaining 8.9% over the past six months compared to a 12.4% decline in the industry [4]